CEPI: Innovative analytical technologies to improve vaccine manufacturing speed and equitable access

Who can apply – Individual organisations or consortia developing relevant analytical technologies. The technology must already have demonstrated that it works; purely conceptual/idea-stage technologies are not eligible.

Vaccine modalities – Technologies must be applicable to at least one proven vaccine modality: RNA/LNP, viral-vector or protein-based vaccines. Ideally platforms should benefit multiple vaccine candidates, including vaccines against future novel viral threats (“Disease X”).